Future US Transfusion Diagnostic Testing Market Outlook
Venture Planning Group
February 9, 2012 460 Pages - SKU: VPG6800963
|
|
Countries covered: United States
Highlights- Comprehensive 460-pages market segmentation analysis of the US transfusion testing market.
- Major issues pertaining to the US transfusion testing practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Specifically, the study explores the impact of anticipated changes in government regulations, trends in complicated surgeries, birth rate and other key issues.
- Ten-year volume and sales forecasts for 40 blood typing, grouping and infectious disease screening tests, including NAT procedures performed in US community and regional blood centers, hospitals, commercial laboratories, and plasma fractionation facilities.
- Annual placements and installed base estimates for major automated and semi-automated analyzers.
- Review of current instrumentation technologies, and a feature comparison of over 20 analyzers.
- Ten-year reagent and instrument sales forecasts.
- Sales and market shares of leading reagent and instrument suppliers.
- Review of current and emerging technologies, and their potential market applications.
- Product development opportunities for instruments ,consumables, and auxiliary products.
- Profiles of major current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.
- Business opportunities and strategic recommendations for suppliers.
Contains 460 pages and 53 tables
Please note: The delivery time for the electronic version of this report is between 1-3 business days to allow the preparation of an updated version prior to dispatch.
|
A. Major Blood Typing, Grouping and Infectious Disease Screening Tests
- 1. Blood Typing and Grouping Tests
- a. ABO
- b. Antibody Panels
- c. Antibody Screening
- d. Antigen Typing
- e. Antiglobulin Test
- f. Crossmatch
- g. HLA Typing
- h. Rh
- i. Other Blood Groups
- 2. Infectious Disease Screening Tests
- a. AIDS
- - Structure and Composition
- - Classification
- - Origin of AIDS
- - Animal Lentivirus Systems
- - Virus Receptors
- - HIV Infections in Humans
- -Pathogenesis & Pathology
- -Overview of Course of HIV Infection
- - CD4T Lymphocytes and Memory Cells
- - Monocytes and Macrophages
- - Lymphoid Organs
- - Neural Cells
- - Viral Coinfections
- -Clinical Findings
- - Plasma Viral Load
- - Pediactric AIDS
- -Neurologic Disease
- -Opportunistic Infections
- -Protozoa
- -Fungi
- -Bacteria
- -Viruses
- -Cancer
- - Immunity
- - Laboratory Diagnosis
- -Virus Isolation
- -Serology
- -Detection of Viral Nucleic Acid or Antigens
- - Epidemiology
- -Worldwide Spread of AIDS
- -United States
- -Routes of Transmission
- - Prevention, Treatment, And Control
- -Antiviral Drugs
- -Vaccines Against HIV
- - Transmission of HIV in Blood Products
- - HIV Transmission in Transplant and Artificial Insemination Recipients
- - Diagnostic Tests
- -Enzyme Immunoassay Interpretation
- -Specificity, Sensitivity, and Predictive Value of Enzyme Immunoassay
- - Competition Assays
- - Western Blot Technique
- - Immuno-Fluorescence Assay (IFA)
- - Radioimmunoprecipitation
- - HIV-1/HIV-2 Combination Testing
- - Methods of HIV-Antigen Detection
- - Antigen Assays and Blood Screening
- - Urine Tests
- - DNA Probes
- - Overview
- - Quantitative Polymerase Chain Reaction
- - In Situ PCR
- - Needed Improvements
- - Viral Load/Drug Resistance Testing
- - Genotype and Phenotype Testing
- - Blood Banking Considerations
- b. Hepatitis
- - Hepatitis A
- - Hepatitis B
- -Structure and Composition
- -Replication of Hepatitis B Virus
- - Hepatitis C
- - Hepatitis D (Delta Hepatitis)
- - Hepatitis E
- - Hepatitis G
- - Hepatitis Virus Infections In Humans
- -Pathology
- - Clinical Findings
- - Laboratory Features
- -Hepatitis A
- -Hepatitis B
- -Hepatitis C
- -Hepatitis D
- -Hepatitis E
- - Virus-Host Immune Reactions
- - Epidemiology
- -Hepatitis A
- -Hepatitis B
- -Hepatitis C
- -Hepatitis D (Delta Agent)
- - Vaccines and Drugs
- c. Cytomegalovirus
- - Background
- - Chorioretinitis
- - Gastrointestinal
- - Central Nervous System Disease
- - Diagnostic Tests
- - Vaccines and Drugs
- d. Syphilis
- - Background
- - Diagnostic Tests
- - Vaccines and Drugs
- e. West Nile Virus
- - Background
- - Clinical Syndromes
- - Diagnostic Tests
- - Vaccines and Drugs
- f. Parvovirus B19
- - Microbiology
- - Epidemiology
- - Clinical Syndromes
- -Erythema Infectiosum Slapped (cheek)
- -Adult Polyarthropathy
- -Transient Aplastic Crisis
- -Transient Pancytopenia
- -Red Cell Aplasia in the Immunocompromised
- -Perinatal Infections
- - Diagnosis
- - Treatment
- g. Creutzfeldt-Jakob’s Disease
- - Background
- - Transmission
- - Diagnostic Tests
- - Major Commercial and Academic Players
- -Bayer
- -Disease Sciences/BioTec Global
- -Imperial College School of Medicine
- -Ortho-Clinical Diagnostics
- -Pall
- -ProMetic Life Sciences
- -Proteome Sciences/Idexx
- -Q-One Biotech
- -Serono
- -U.S. Agricultural Research Service
- - Drugs
- - Vaccines
- h. Malaria
- i. Chagas Disease
- j. Babesiosis
- 3. Pathogen Reduction
- 4. Leukocyte Reduction
- - Background
- - Methods
- B. Instrumentation Review Introduction
- 1. Abbott Architect i2000 Series
- 2. Abbott AxSYM
- 3. Abbott LCx
- 4. Abbott Prism
- 5. Abbott Quantum II
- 6. Beckman Coulter/Biomek FX
- 7. Beckman Coulter BloodTrack Courier
- 8. Beckman Coulter OLA2500
- 9. Beckman Coulter PK7100
- 10. Beckman Coulter PK7200
- 11. Beckman Coulter PK80
- 12. Beckman Coulter Tango
- 13. Bio-Rad Elite
- 14. Bio-Rad GeneScope
- 15. BioMerieux Bac/Alert
- 16. Gen-Probe Tigris
- 17. Grifols Diana
- 18. Immucor ABS2000
- 19. Immucor Galileo
- 20. Immucor Rosys Plato System
- 21. Nanosphere Verigen Series
- 22. Ortho AutoVue/ProVue
- 23. Ortho StarFame Combo
- 24. Ortho Summit Processor
- 25. Roche Cobas Amplicor
- 26. Roches Cobas s 201
- 27. Sarstedt PVS
- 28. Siemens BEP 2000
- 29. Siemens Quadriga
- 30. Siemens SDA
- 31. Tecan ELPHAtyper
- 32. Tecan Genesis FE500
- 33. Tecan Hemotyper
- 34. Tecan LS Series
- 35. Tecan MegaFlex
- 36. Tecan MiniSwift
- C. Major in Vitro Diagnostic Technologies And Their Potential Applications
- 1. Molecular Diagnostics
- a. Overview
- b. NAT
- 2. Monoclonal and Polyclonal Antibodies
- 3. Immunoassays
- a. Technological Principle
- b. Enzyme Immunoassays (EIA)
- - Overview
- - ELISA
- - Enzyme Amplification
- c. Fluorescent Immunoassays
- - Fluorescence Polarization
- d. Luminescence
- - Chemiluminescence
- - Bioluminescence
- e. Latex Agglutination
- f. Immunoprecipitation
- 4. Microtitration Plates
- 5. Information Technology
- 6. Automation
- 7. Lasers
- 8. Robotics
- 9. Artificial Intelligence
- 10. Synthetic Red Cell Substitutes
- 11. Genetically Engineered Blood Components
- a. Albumin
- b. Factor VIII
- c. Alpha-2 Antiplasmin
- d. Antithrombin III
- e. Factor IX
- f. Von Willebrand's Factor
- g. Fibrinogen
- h. t-PA
- 12. Blood Preservation
- 13. Autologous Blood Transfusion/Freezing
- D. Worldwide Market Overview
- 1. Business Environment
- 2. Market Structure
- 3. Market Size and Growth
- U.S.A.
- A. Executive Summary
- B. Business Environment
- 1. Overview
- 2. Health Care Expenditures
- 3 Cost Consciousness
- 4. Industry Consolidation
- 5. Managed Care
- 6. Hospitals
- 7. Admissions
- 8. Length of Stay
- 9. Industry Diversification
- 10. Physician Demographics
- 11. Population Aging
- a. Chronic Illnesses
- b. Disease Incidence
- c. Susceptibility to Latrogenesis
- d. Multiple Illness Cases
- 12. Laboratory Regulations
- C. Market Structure
- D. Market Size, Growth and Major Suppliers’ Consumable Sales, Instrument Placements, Installed Base and Market Shares
- Major Product Development Opportunities
- A. Blood Typing and Grouping
- B. Infectious Disease Screening
- C. Auxiliary
- Alternative Market Penetration Strategies
- A. Internal Development
- B. Collaborative Arrangements
- C. University Contracts
- Potential Market Entry Barriers and Risks
- A. Market Maturity
- B. Cost Containment
- C. Competition
- D. Technological Edge And Limitations
- E. Patent Protection
- Competitive Assessments
- - Abbott
- - Beckman Coulter
- - Becton Dickinson
- - Biokit
- - BioMerieux
- - Bio-Rad
- - Diagast
- - DiaSorin
- - Fujirebio
- - Gen-Probe
- - Grifols
- - Immucor
- - Innogenetics
- - Ortho-Clinical Diagnostics
- - Orchid CellMark
- - Novartis Diagnostics
- - Proteome Sciences
- - Roche
- - Siemens
- - Tecan
- List of Tables
- Major Companies Developing or Marketing Blood Typing and Grouping Tests
- Major Companies Developing or Marketing HLA Typing Tests
- Major Companies Developing or Marketing AIDS Tests
- Major Companies Developing or Marketing Hepatitis Tests
- Major Companies Developing or Marketing CMV Tests
- Major Companies Developing or Marketing Syphilis Tests
- Major Companies Developing or Marketing Blood Bank Analyzers
- Worldwide, All Market Segments, Facilities Performing Blood Bank Tests By Country
- Worldwide, All Market Segments, Total Blood Typing and Grouping Test Volume Forecast By Country
- Worldwide, All Market Segments, Total Infectious Disease Screening Test Volume Forecast
- Worldwide, All Market Segments, Total Blood Typing and Grouping Reagent Market Forecast By Country
- Worldwide, All Market Segments, Total Infectious Disease Reagent Market Forecast By Country
- Executive Summary Table: U.S.A., Total Blood Bank Test Volume and Reagent Sales Forecast By Test Category
- U.S.A., Estimated Number of Inpatient and Ambulatory Surgeries
- U.S.A., Facilities Performing Blood Bank Tests By Market Segment
- U.S.A., Hospital Laboratories Performing Blood Bank Tests By Bed Size
- U.S.A., Commercial/Private Laboratories Performing Blood Bank Tests By Annual Test Volume Forecast
- U.S.A., Facilities Collecting Whole Blood and Plasma By Market Forecast Segment
- U.S.A., Whole Blood and Plasma Collections By Market Forecast Segment
- U.S.A., All Market Segments Blood Typing and Grouping Test Volume By Market Forecast Segment
- U.S.A., All Market Segments Blood Typing and Grouping Test Volume Forecast
- U.S.A., Hospital Laboratories Blood Typing and Grouping Test Volume Forecast
- U.S.A., Community and Regional Blood Centers Blood Typing and Grouping Test Volume Forecast
- U.S.A., Commercial/Private Laboratories Blood Typing and Grouping Test Volume Forecast
- U.S.A., Plasma Fractionation Centers Blood Typing and Grouping Test Volume Forecast
- U.S.A., Military Blood Banks Blood Typing and Grouping Test Volume Forecast
- U.S.A., All Market Segments Infectious Disease Screening Test Volume Forecast By Market Segment
- U.S.A., All Market Segments Infectious Disease Screening Test Volume Forecast
- U.S.A., Community and Regional Centers Infectious Disease Screening Test Volume Forecast
- U.S.A., Plasma Fractionation Centers Infectious Disease Screening Test Volume Forecast
- U.S.A., Hospital Blood Banks Infectious Disease Screening Test Volume Forecast
- U.S.A., Military Blood Banks Infectious Disease Screening Test Volume Forecast
- U.S.A., All Market Segments Blood Typing and Grouping Reagent Market Forecast By Market Segment
- U.S.A., All Market Segments Blood Typing and Grouping Reagent Market Forecast By Market Segment
- U.S.A., Hospital Blood Banks Blood Typing And Grouping Reagent Market Forecast by Major Test
- U.S.A., Community and Regional Blood Centers Blood Typing and Grouping Reagent Market Forecast By Major Test
- U.S.A., Commercial/Private Laboratories Blood Typing and Grouping Reagent Market Forecast By Major Test
- U.S.A., Plasma Fractionation Centers Blood Typing and Grouping Reagent Market Forecast By Major Test
- U.S.A., Military Blood Banks Blood Typing And Grouping Reagent Market Forecast By Major Test
- U.S.A., All Market Segments Infectious Disease Screening Reagent Market By Market Forecast Segment
- U.S.A., All Market Segments Infectious Disease Screening Reagent Market By Market Forecast Segment
- U.S.A., Community and Regional Centers Infectious Disease Screening Reagent Market Forecast By Test
- U.S.A., Plasma Fractionation Centers Infectious Disease Screening Reagent Market Forecast By Test
- U.S.A., Hospital Blood Banks Infectious Disease Screening Reagent Market Forecast By Test
- U.S.A., Military Blood Banks Infectious Disease Screening Reagent Market Forecast By Test
- U.S.A., Major Suppliers of Blood Typing and Grouping Reagents Estimated Sales and Market Shares
- U.S.A., HIV/HTLV Blood Screening Market, Reagent Sales by Major Supplier
- U.S.A., Hepatitis Blood Screening Market, Reagents Sales by Major Supplier
- U.S.A., Hepatitis C Blood Screening Market, Reagent Sales By Major Supplier
- U.S.A., HIV/Hepatitis C NAT Market, Reagent Sales By Major Supplier
- U.S.A., West Nile Virus NAT Market, Reagent Sales By Major Supplier
- U.S.A., CMV Blood Screening Market, Reagent Sales By Major Supplier
- U.S.A., Syphilis Blood Screening Market, Reagent Sales By Major Supplier
More United States Histology & Cytology Reports
2012 US Transfusion Diagnostic Testing Market Outlook: Growth Opportunities and Strategies by
Venture Planning Group
Highlights Comprehensive 460-pages market segmentation analysis of the US transfusion testing market. Major issues pertaining to the US transfusion testing practice, as well as key economic, regulatory, ...
2012 US Hematology and Flow Cytometry Market Outlook: Growth Opportunities and Strategies by
Venture Planning Group
This report presents a comprehensive analysis of the US hematology and flow cytometry markets, including: Major issues pertaining to the US hematology and flow cytometry practice, ...
2012 US Flow Cytometry Market Outlook: Growth Opportunities and Strategies by
Venture Planning Group
This report presents a comprehensive analysis of the US flow cytometry market, including: Major issues pertaining to the US flow cytometry practice, as well as key ...
Strategic Implications of Innovative, Technological and Market Trends for the US Diagnostics Market by
Venture Planning Group
How will the future reimbursement changes affect individual market segments? Will the industry consolidate, decentralize, or undergo a bimodal transformation? What will be the impact on purchasing ...
The 2012 US Hematology and Flow Cytometry Markets by
Venture Planning Group
This report presents a comprehensive analysis of the US hematology and flow cytometry markets, including: Major issues pertaining to the US hematology and flow cytometry practice, ...
See all reports like this >>
More United States Reports
e-Discovery Software Publishing in the US - Industry Market Research Report by
IBISWorld
e-Discovery Software Publishing in the US Finding growth : Electronic discovery (more often known as e-discovery) refers to a data search, location and securing process for use ...
D&B Country RiskLine Report: The United States of America by
Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...
D&B Country Report: The United States of America by
Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...
Country Report United States January 2011 by
Economist Intelligence Unit
Country Reports analyse political and economic trends in featured countries. They show you exactly how national, regional and global events will affect your business in ...
Coal - US - a snapshot (2010) by
Mintel - Snapshots
Coal in US by Mintel Global Market Navigator provides you with annual year-end market size data, most recently updated in 2010. This market covers consumption ...
See all reports like this >>
Share this report
Other tasks Related Markets Histology & Cytology Reports Free Alert Me service Receive bi-weekly email alerts on new market research Sign Up Today!
|
